Trial results posted: A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

ClinicalTrials.gov records the first posting of results for study NCT05620836 on 2026-11-05. A registry posting does not establish that a treatment is effective or safe.

Why it matters

New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.

What remains uncertain

• The study findings have not been independently assessed by NULLPEN.

The source record

National Library of Medicine, National Institutes of Health